Patch testing for corticosteroid allergy using high and low concentrations

Contact Dermatitis

Volumn 42, Issue 6, 2000, Pages 350-351

  Wilkinson, S M ^b   Beck, M H ^a  

^a HOPE HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Budesonide; Concentration; Corticosteroids; Medicaments; Patch test method; Tixocortol pivalate

Indexed keywords

BUDESONIDE; CORTICOSTEROID; TIXOCORTOL PIVALATE;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG HYPERSENSITIVITY; HUMAN; MAJOR CLINICAL STUDY; PATCH TEST; SKIN MANIFESTATION;

ANTI-INFLAMMATORY AGENTS; BUDESONIDE; DERMATITIS, ALLERGIC CONTACT; DRUG HYPERSENSITIVITY; HUMANS; HYDROCORTISONE; PATCH TESTS; SKIN;

EID: 0034126383     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. 1. Isaksson M, Bruze M, Goossens A, Lepoittevin J P. Patch testing with budesonide in serial dilutions: the significance of dose, occlusion time and reading time. Contact Dermatitis 1999: 40: 24-31.
2. 2. Isaksson M, Bruze M, Matura M, Goossens A. Patch testing with low concentrations of budesonide detects contact allergy. Contact Dermatitis 1997: 37: 241-242.
3. 3. Isaksson M, Bruze M, Björkner B, Hindsen M, Svensson L. The benefit of patch testing with a corticosteroid at a low concentration. Am J Contact Dermatitis 1999: 10: 31-33.
4. 4. Bjarnason B, Flosadottir E, Fischer T. Assessment of budesonide patch tests. Contact Dermatitis 1999: 41: 211-217.
5. 5. Wilkinson S M, Beck M H. Corticosteroid contact hypersensitivity: what vehicle and concentration? Contact Dermatitis 1996: 34: 305-308.
6. 6. Seukeran D C, Wilkinson S M and Beck M H. Patch testing to detect corticosteroid allergy: is it adequate? Contact Dermatitis 1997: 37: 127-130.